<!DOCTYPE html>
<html>
<head>
<title>Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="https://ir.pressurebiosciences.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://ir.pressurebiosciences.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1170">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1170">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1171">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1171">Consolidated Balance Sheets (Unaudited)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1172">Consolidated Balance Sheets (Unaudited) (Parenthetical)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1173">Consolidated Statements of Operations (Unaudited)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1174">Consolidated Statements of Cash Flows (Unaudited)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1175">Consolidated Statements of Equity (Unaudited)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1176">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1176">Business Overview, Liquidity and Management Plans</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1177">Going Concern</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1178">Interim Financial Reporting</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1179">Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1180">Commitments and Contingencies</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1181">Convertible Debt and Other Debt</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1182">Stockholders' Deficit</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1183">Subsequent Events</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1184">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1184">Summary of Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1185">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1185">Summary of Significant Accounting Policies (Tables)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1186">Commitments and Contingencies (Tables)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1187">Convertible Debt and Other Debt (Tables)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1188">Stockholders' Deficit (Tables)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1189">Subsequent Events (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1190">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1190">Business Overview, Liquidity and Management Plans (Details Narrative)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1191">Summary of Significant Accounting Policies (Details Narrative)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1192">Summary of Significant Accounting Policies - Schedule of Disaggregation of Revenue (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1193">Summary of Significant Accounting Policies - Schedule of Contract Balances (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1194">Summary of Significant Accounting Policies - Schedule of Future Related to Performance Obligations (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1195">Summary of Significant Accounting Policies - Schedule of Customer Concentration Risk Percentage (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1196">Summary of Significant Accounting Policies - Schedule of Computation of Loss Per Share (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1197">Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1198">Summary of Significant Accounting Policies - Schedule of Stock Based Compensation Expense (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1199">Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1200">Commitments and Contingencies (Details Narrative)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1201">Commitments and Contingencies - Schedule of Future Minimum Rental Payments Required Under Operating Leases (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1202">Convertible Debt and Other Debt (Details Narrative)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1203">Convertible Debt and Other Debt - Schedule of Convertible Debt (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1204">Convertible Debt and Other Debt - Schedule of Convertible Debts and Outstanding Balances (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1205">Convertible Debt and Other Debt - Summary of Changes in Convertible Debt and Revolving Note Payable, Net of Unamortized Discounts (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1206">Convertible Debt and Other Debt - Schedule of Merchant Agreements (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1207">Stockholders' Deficit (Details Narrative)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1208">Stockholders' Deficit - Schedule of Concerning Options and Warrants Outstanding and Exercisable (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1209">Stockholders' (Deficit) - Schedule of Share-based Compensation Stock Option Plans by Exercise Price Range (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1210">Subsequent Events (Details Narrative)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1211">Subsequent Events - Schedule of Convertible Loan Modifications and Extinguishments (Details)</a></li>
                                                            <li><a href="https://ir.pressurebiosciences.com/annual-reports/xbrl_doc_only/1212">Subsequent Events - Schedule of Convertible Loan Modifications and Extinguishments (Details) (Parenthetical)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Stockholders' Deficit</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>